Exelon Corp: Form 10-Q for the period ended Sep 30, 2023
Filed with the SEC on Nov 2, 2023 and accepted by EDGAR at Nov 2, 2023, 14:36 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-07-01 to 2023-09-30 | $5.98bn | us-gaap:Revenues |
| Revenue | 9 months2023-01-01 to 2023-09-30 | $16.36bn | us-gaap:Revenues |
| Operating income | 3 months2023-07-01 to 2023-09-30 | $1.12bn | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-01-01 to 2023-09-30 | $2.93bn | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-07-01 to 2023-09-30 | $67.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-01-01 to 2023-09-30 | $274.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-07-01 to 2023-09-30 | $700.0m | us-gaap:ProfitLoss |
| Net income | 9 months2023-01-01 to 2023-09-30 | $1.71bn | us-gaap:ProfitLoss |
| Diluted shares (weighted) | 3 months2023-07-01 to 2023-09-30 | 997,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-01-01 to 2023-09-30 | 996,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-01-01 to 2023-09-30 | $3.29bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-01-01 to 2023-09-30 | $5.54bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2023-01-01 to 2023-09-30 | $1.07bn | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2023-09-30 | $300.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-09-30 | $7.52bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-09-30 | $99.26bn | us-gaap:Assets |
| Current liabilities | At period end2023-09-30 | $8.80bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-09-30 | $73.79bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-09-30 | $39.43bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2023-09-30 | $1.72bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-09-30 | $25.47bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2023-09-30 | 995,437,416 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001109357-23-000097. Last ingested by Listed: Oct 30, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.